SCHEMBL17986792

SCHEMBL17986792

CCS(=O)(=O)c1cc(C2(C(=O)OC)CC2)cnc1-c1nc2cc(C(F)(F)F)cnc2n1C

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.43
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ LRRK2 Q5S007 2/20 0.34
▸ SCN10A Q9Y5Y9 3/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ RECQL P46063 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ LMNA P02545 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ SSTR4 P31391 1/20 0.31
▸ CNR1 P21554 1/20 0.31
▸ CHRNA7 P36544 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ GPR119 Q8TDV5 1/20 0.30
▸ ALK Q9UM73 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17844036 0.91 POLB (0.43) POLBMEN1KMT2ALRRK2SCN10A
SCHEMBL17844159 0.90 POLB (0.42) POLBMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL17986795 0.85 POLB (0.47) POLBMEN1KMT2ASCN10ASMN1; SMN2
SCHEMBL29360277 0.83 POLB (0.48) POLBMEN1KMT2ALRRK2ALDH1A1
SCHEMBL14684583 0.83 POLB (0.48) POLBMEN1KMT2ALRRK2ALDH1A1
SCHEMBL15947511 0.83 POLB (0.47) POLBMEN1KMT2ALRRK2L3MBTL1
SCHEMBL29904936 0.82 POLB (0.39) POLBLRRK2ALDH1A1
SCHEMBL17844096 0.82 POLB (0.39) POLBLRRK2ALDH1A1
SCHEMBL17329176 0.81 POLB (0.46) POLBMEN1KMT2ALRRK2L3MBTL1
SCHEMBL18401201 0.81 POLB (0.45) POLBMEN1KMT2ALRRK2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266552-B2 Condensed heterocyclic compound having cycloalkylpyridyl group or salt thereof, agricultural and horticultural insecticide comprising the compound, and method for using the insecticide NIHON NOHYAKU CO., LTD. (JP) 2019-04-23 — — US disclosed
WO-2016121997-A1 FUSED HETEROCYCLIC COMPOUND HAVING CYCLOALKYLPYRIDYL GROUP OR SALT THEREOF, AND AGRICULTURAL OR HORTICULTURAL INSECTICIDE CONTAINING SAID COMPOUND AND USE METHOD THEREFOR 日本農薬株式会社 2016-08-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10266552-B2 Condensed heterocyclic compound having cycloalkylpyridyl group or salt thereof, agricultural and horticultural insecticide comprising the compound, and method for using the insecticide DDT, HCN3, HCN1 POLB 3724/4885MEN1 748/4885KMT2A 170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback